Supernus Pharmaceuticals
SUPN
#4328
Rank
โ‚น166.15 B
Marketcap
โ‚น3,009
Share price
-0.95%
Change (1 day)
23.77%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น28.49 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are โ‚น28.49 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น29.64 B-56.11%
2022-12-31โ‚น67.54 B3.92%
2021-12-31โ‚น65.00 B17.06%
2020-12-31โ‚น55.52 B37.85%
2019-12-31โ‚น40.28 B9.77%
2018-12-31โ‚น36.69 B266.08%
2017-12-31โ‚น10.02 B25.2%
2016-12-31โ‚น8.00 B19.73%
2015-12-31โ‚น6.68 B9.8%
2014-12-31โ‚น6.08 B27.14%
2013-12-31โ‚น4.78 B140.21%
2012-12-31โ‚น1.99 B-14.89%
2011-12-31โ‚น2.34 B-42.75%
2010-12-31โ‚น4.09 B2.49%
2009-12-31โ‚น3.99 B-0.96%
2008-12-31โ‚น4.03 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น86.81 B 204.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.204 T 18,164.35%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.494 T 22,689.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2.915 T 10,130.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น9.183 T 32,124.31%๐Ÿ‡บ๐Ÿ‡ธ USA